Litcius/Paper detail

860MO MRG003: A novel EGFR-targeted antibody-drug conjugant (ADC) for recurrent/metastatic nasopharyngeal carcinoma

Fei Han, Fei Wang, Y-R. Shi, Ye Guo, X-L. shu, Shiyang Pan, S Q Qu, Ping Zhang, Yi Jiang, M-J. Xu, Kaijian Lei, Song Qu, F. Lei, Xing Lv, Y-Q. Xiang, R-H. Xu

2023Annals of Oncology12 citationsDOIOpen Access PDF

Topics & Concepts

MedicineNasopharyngeal carcinomaOncologyDrugInternal medicineAntibodyRadiation therapyPharmacologyImmunologyRadiopharmaceutical Chemistry and ApplicationsLung Cancer Treatments and MutationsMedical Imaging Techniques and Applications
860MO MRG003: A novel EGFR-targeted antibody-drug conjugant (ADC) for recurrent/metastatic nasopharyngeal carcinoma | Litcius